REVIEW
Year : 2014  |  Volume : 16  |  Issue : 2  |  Page : 274-279

Differential expression of 5-alpha reductase isozymes in the prostate and its clinical implications


Department of Urology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China

Correspondence Address:
Yi-Nong Niu
Department of Urology, Beijing Chaoyang Hospital, Capital Medical University, Beijing
China
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1008-682X.123664

Rights and Permissions

The development of human benign or malignant prostatic diseases is closely associated with androgens, primarily testosterone (T) and dihydrotestosterone (DHT). T is converted to DHT by 5-alpha reductase (5-AR) isozymes. Differential expression of 5-AR isozymes is observed in both human benign and malignant prostatic tissues. 5-AR inhibitors (5-ARI) are commonly used for the treatment of benign prostatic hyperplasia (BPH) and were once promoted as chemopreventive agents for prostate cancer (PCa). This review discusses the role of the differential expression of 5-AR in the normal development of the human prostate and in the pathogenesis and progression of BPH and PCa.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed4894    
    Printed94    
    Emailed0    
    PDF Downloaded591    
    Comments [Add]    
    Cited by others 8    

Recommend this journal